Hm Payson & CO Bristol Myers Squibb CO Transaction History

Hm Payson & CO

$5.49 Billion
Q2 2024

A detailed history of Hm Payson & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hm Payson & CO holds 97,803 shares of BMY stock, worth $5.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

97,803

Previous 102,716 4.78%

Holding current value

$5.2 Million

Previous $5.57 Million 27.09%

% of portfolio

0.07%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $197,748 - $260,339	-4,913 Reduced 4.78%	97,803 $4.06 Million
Q1 2024 Jun 20, 2024	SELL	$47.98 - $54.4 $1.12 Million - $1.27 Million	-23,277 Reduced 18.47%	102,716 $5.57 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $4.38 Million - $5.22 Million	-90,270 Reduced 41.74%	125,993 $6.46 Million
Q3 2023 Nov 06, 2023	SELL	$57.89 - $64.73 $37.7 Million - $42.2 Million	-651,425 Reduced 75.08%	216,263 $12.6 Million
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $15.7 Million - $17.4 Million	-246,133 Reduced 22.1%	867,688 $55.5 Million
Q1 2023 Apr 18, 2023	BUY	$65.71 - $74.53 $480,800 - $545,336	7,317 Added 0.66%	1,113,821 $77.2 Million
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $7.33 Million - $8.68 Million	107,063 Added 10.71%	1,106,504 $79.6 Million
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $58,456 - $34.6 Million	449,663 Added 81.79%	999,441 $71.1 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $5.35 Million - $5.89 Million	73,688 Added 15.48%	549,778 $42.3 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $23.4 Million - $28.1 Million	381,214 Added 401.8%	476,090 $34.8 Million
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $85,593 - $99,781	-1,596 Reduced 1.65%	94,876 $5.92 Million
Q3 2021 Nov 30, 2021	BUY	$59.17 - $69.31 $20,117 - $23,565	340 Added 0.35%	96,472 $5.71 Million
Q2 2021 Aug 17, 2021	SELL	$61.91 - $67.42 $8,172 - $8,899	-132 Reduced 0.14%	96,132 $6.42 Million
Q1 2021 Jun 15, 2021	SELL	$59.34 - $66.74 $771 - $867	-13 Reduced 0.01%	96,264 $6.08 Million
Q4 2020 Mar 10, 2021	SELL	$57.74 - $65.43 $164,270 - $186,148	-2,845 Reduced 2.87%	96,277 $5.97 Million
Q3 2020 Dec 21, 2020	SELL	$57.43 - $63.64 $918 - $1,018	-16 Reduced 0.02%	99,122 $5.98 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $4,385 - $5,127	80 Added 0.08%	99,138 $5.83 Million
Q1 2020 Jul 01, 2020	SELL	$46.4 - $67.43 $326,841 - $474,976	-7,044 Reduced 6.64%	99,058 $5.52 Million
Q4 2019 Feb 18, 2020	BUY	$49.21 - $64.19 $363,071 - $473,593	7,378 Added 7.47%	106,102 $6.81 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $238,271 - $282,505	5,571 Added 5.98%	98,724 $5.01 Million
Q2 2019 Aug 15, 2019	SELL	$44.62 - $49.34 $89,329 - $98,778	-2,002 Reduced 2.1%	93,153 $4.23 Million
Q1 2019 Jul 31, 2019	BUY	$45.12 - $53.8 $4.29 Million - $5.12 Million	95,155 New	95,155 $4.54 Million
Q4 2018 Feb 15, 2019	SELL	$48.76 - $63.23 $3.64 Million - $4.73 Million	-74,745 Closed	0 $0
Q3 2018 Nov 30, 2018	SELL	$55.19 - $62.25 $832,044 - $938,481	-15,076 Reduced 16.78%	74,745 $4.64 Million
Q2 2018 Aug 27, 2018	BUY	$50.53 - $62.98 $5,356 - $6,675	106 Added 0.12%	89,821 $4.97 Million
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $50,752 - $58,426	-847 Reduced 0.94%	89,715 $5.67 Million
Q4 2017 Feb 16, 2018	BUY	$59.94 - $65.35 $90,749 - $98,939	1,514 Added 1.7%	90,562 $5.55 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $4.92 Million - $5.68 Million	89,048	89,048 $5.68 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account